Christopher P. Mill, Ph.D.

Affiliations: 
2011 Medicinal Chemistry and Molecular Pharmacology Purdue University, West Lafayette, IN, United States 
Area:
Molecular Biology, Pharmacology, Cell Biology
Google:
"Christopher Mill"
Mean distance: (not calculated yet)
 

Parents

Sign in to add mentor
David J. Riese grad student 2011 Purdue
 (The ErbB4 receptor tyrosine kinase couples to divergent biological responses in a context-dependent manner.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Lucas LM, Dwivedi V, Senfeld JI, et al. (2022) The Yin and Yang of ERBB4: Tumor Suppressor and Oncoprotein. Pharmacological Reviews. 74: 18-47
Cullum RL, Lucas LM, Senfeld JI, et al. (2020) Development and application of high-throughput screens for the discovery of compounds that disrupt ErbB4 signaling: Candidate cancer therapeutics. Plos One. 15: e0243901
Kabir FM, DeInnocentes P, Agarwal P, et al. (2016) Estrogen receptor-α, progesterone receptor and c-erbB/HER-family receptor mRNA detection and phenotype analysis in spontaneous canine models of breast cancer. Journal of Veterinary Science
Kanthala S, Mill CP, Riese DJ, et al. (2015) Expression And Purification Of HER2 Extracellular Domain Proteins In Schneider2 Insect Cells. Protein Expression and Purification
Gallo RM, Bryant IN, Mill CP, et al. (2013) Multiple Functional Motifs Are Required for the Tumor Suppressor Activity of a Constitutively-Active ErbB4 Mutant. Journal of Cancer Research and Therapeutic Oncology. 1: 10
Nickerson NK, Mill CP, Wu HJ, et al. (2013) Autocrine-derived epidermal growth factor receptor ligands contribute to recruitment of tumor-associated macrophage and growth of basal breast cancer cells in vivo. Oncology Research. 20: 303-17
Wilson KJ, Mill C, Lambert S, et al. (2012) EGFR ligands exhibit functional differences in models of paracrine and autocrine signaling. Growth Factors (Chur, Switzerland). 30: 107-16
Wilson KJ, Mill CP, Gallo RM, et al. (2012) The Q43L mutant of neuregulin 2β is a pan-ErbB receptor antagonist. The Biochemical Journal. 443: 133-44
Mill CP, Zordan MD, Rothenberg SM, et al. (2011) ErbB2 Is Necessary for ErbB4 Ligands to Stimulate Oncogenic Activities in Models of Human Breast Cancer. Genes & Cancer. 2: 792-804
Zordan MD, Mill CP, Riese DJ, et al. (2011) A high throughput, interactive imaging, bright-field wound healing assay. Cytometry. Part a : the Journal of the International Society For Analytical Cytology. 79: 227-32
See more...